RecruitingNot ApplicableNCT07120906
Augmented Reality Real-Time Guidance for MRI-Guided Interventions
Sponsor
Mayo Clinic
Enrollment
10 participants
Start Date
Jul 25, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this research is to evaluate the safety and feasibility of using a needle guidance system (LUMENA) create by CLEAR GUIDE MEDICAL for needle placement for biopsy or liver tumor ablation procedures.
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Inclusion Criteria4
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, ages 18-90 years
- Patient referred to Interventional Radiology for image-guided liver needle placement for ablation/biopsy.
Exclusion Criteria3
- Patients who are unable to give informed consent themselves or through their parents.
- Patients that do not fit into MR scanner (70 cm bore) with room for needle placement.
- Contraindications to MRI such as MR-unsafe implants.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEMRI guided procedure software evaluation
For the use of the MRI-needle guidance system (LUMENA) developed by CLEAR GUIDE MEDICAL during clinical MRI-guided needle placement procedures for patients undergoing a liver biopsy/procedure.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07120906
Related Trials
Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection
NCT058791591 location
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
NCT061959431 location
The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region
NCT065615292 locations